Candesic named Consultants of the Year – Strategy at HealthInvestor Awards 2025

Multiple award-winning consultancy Candesic was delighted to be named as “Consultants of the Year for Strategy” at the HealthInvestor Awards 2025.

Candesic offers a unique value proposition to its clients: CEO level clarity with R&D level insight.

The London and New York-based specialist healthcare, social care and life sciences group was recognised for its innovative work pioneering the ground-breaking tech supported strategy Candesic SiA (Strategy in Action).

Led by partner Marc Kitten, SiA combines software automation, tailored databases and world-class consultant support to guide clients through the strategic development process including workshops, training and coaching – a unique departure from traditional “outside” consulting. SiA gives the client unprecedented buy-in and ownership as, with Candesic’s peerless support, they develop their own strategy.

Over the last year SiA has demonstrably and reliably delivered robust, responsive and actionable strategy aligned with clear KPIs and long-term objectives.

Now deployed by multiple groups, Candesic SiA is transforming the way they do business, with eye-catching results which are delighting clients.

Alongside SiA, Candesic’s flourishing traditional consultancy work with a broad range of clients including independent providers, policy makers, NHS trusts and not-for-profits was also recognised, as was its recent growth including the group’s newly opened and rapidly growing New York office.

Managing Partner Dr Leonid Shapiro said: “Everything we do at Candesic is focused on improving healthcare and care outcomes. We are proud of this award which recognises the dedication, insight and impact of a truly exceptional team which is passionate about delivering meaningful change across the health and social care sector.

“A heartfelt thank you to our clients for their continued trust, and congratulations to all the other winners and nominees who are making a real difference in the industry.”

As a leading specialist in healthcare and life sciences, Candesic’s consulting work includes strategy, vendor/commercial due diligence, digital and M&A growth.

With an international remit, Candesic works with healthcare corporates, global private equity funds and other private investors as well as their portfolio companies, and public sector organisations like the NHS.

Founded in 2002, it has completed over 700 consulting assignments across Europe, Middle East, the Americas and Australia and boasts a professional team combining deep strategic, medical and scientific expertise.

This is Candesic’s third recent award. The group was named Commercial Due Diligence Provider of the Year at Real Deals Private Equity Awards 2025, and Consultancy of the Year at the 2024 Laing Buisson Awards.

If you would like to know more about Candesic, email enquiry@candesic.com